Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KVASNICKA, Hans Michael")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Immunohistochemistry of whole-organ sections of advanced human laryngeal cancerWITTEKINDT, Claus; SITTEL, Christian; KVASNICKA, Hans Michael et al.European archives of oto-rhino-laryngology. 2006, Vol 263, Num 8, pp 741-746, issn 0937-4477, 6 p.Article

Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entitySCHMITT-GRAEFF, Annette; THIELE, Juergen; ZUK, Irina et al.Haematologica (Roma). 2002, Vol 87, Num 4, pp 392-399, issn 0390-6078Article

Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosisTHIELE, Juergen; KVASNICKA, Hans Michael; ZANKOVICH, Rudolf et al.Annals of hematology (Print). 2001, Vol 80, Num 3, pp 160-165, issn 0939-5555Article

Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disordersTHIELE, Juergen; KVASNICKA, Hans Michael.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 3, pp 219-230, issn 0094-6176, 12 p.Article

Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosisTHIELE, Jürgen; KVASNICKA, Hans Michael; ZANKOVICH, Rudolph et al.Haematologica (Roma). 2000, Vol 85, Num 11, pp 1126-1134, issn 0390-6078Article

The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra veraKVASNICKA, Hans Michael; THIELE, Juergen.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 362-371, issn 0094-6176, 10 p.Article

The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemiasTHIELE, Juergen; KVASNICKA, Hans Michael; ZANKOVICH, Rudolph et al.Haematologica (Roma). 2001, Vol 86, Num 4, pp 368-374, issn 0390-6078Article

Effects of anagrelide on megakaryopoiesis and platelet productionTHIELE, Juergen; KVASNICKA, Hans Michael; SCHMITT-GRAEFF, Annette et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 352-361, issn 0094-6176, 10 p.Article

Bone marrow histopathology in myeloproliferative disorders : Current diagnostic approachTHIELE, Juergen; KVASNICKA, Hans Michael; ORAZI, Attilio et al.Seminars in hematology. 2005, Vol 42, Num 4, pp 184-195, issn 0037-1963, 12 p.Article

Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. An immunohistochemical and morphometric study of sequential trephine biopsiesTHIELE, Juergen; KVASNICKA, Hans Michael; FUCHS, Nina et al.Haematologica (Roma). 2003, Vol 88, Num 10, pp 1130-1138, issn 0390-6078, 9 p.Article

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classificationTHIELE, Jürgen; KVASNICKA, Hans Michael; MÜLLAUER, Leonhard et al.Blood. 2011, Vol 117, Num 21, pp 5710-5718, issn 0006-4971, 9 p.Article

Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patientsTHIELE, Juergen; KVASNICKA, Hans Michael; SCHMITT-GRAEFF, Annette et al.American journal of hematology. 2002, Vol 70, Num 4, pp 283-291, issn 0361-8609Article

European consensus on grading bone marrow fibrosis and assessment of cellularityTHIELE, Jürgen; KVASNICKA, Hans Michael; FACCHETTI, Fabio et al.Haematologica (Roma). 2005, Vol 90, Num 8, pp 1128-1132, issn 0390-6078, 5 p.Article

Fluorescence in situ hybridization confirms the presence of Merkel cell polyomavirus in chronic lymphocytic leukemia cellsHAUGG, Anke Maria; SPEEL, Ernst-Jan Maria; DEEPA PANTULU, Naga et al.Blood. 2011, Vol 117, Num 21, pp 5776-5777, issn 0006-4971, 2 p.Article

Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemiaWICKENHAUSER, Claudia; THIELE, Juergen; PEREZ, Fernando et al.Transplantation. 2002, Vol 73, Num 1, pp 104-111, issn 0041-1337Article

Bone marrow features improve prognostic efficiency in Multivariate risk classification of chronic-phase Ph1+ chronic myelogenous leukemia: a multicenter trialKVASNICKA, Hans Michael; THIELE, Juergen; SCHMITT-GRAEFF, Annette et al.Journal of clinical oncology. 2001, Vol 19, Num 12, pp 2994-3009, issn 0732-183XArticle

Risk models predicting survival after reduced-intensity transplantation for myelofibrosisALCHALBY, Haefaa; YUNUS, Dinah-Rohina; AYUK, Francis et al.British journal of haematology. 2012, Vol 157, Num 1, pp 75-85, issn 0007-1048, 11 p.Article

Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allograftsTHIELE, Juergen; VARUS, E. V. A; WICKENHAUSER, Claudia et al.Transplantation. 2004, Vol 77, Num 12, pp 1902-1905, issn 0041-1337, 4 p.Article

Mixed chimerism of bone marrow CD34+ progenitor cells (genotyping, BCR/ABL analysis) after allogeneic transplantation for chronic myelogenous leukemiaTHIELE, Juergen; WICKENHAUSER, Claudia; KVASNICKA, Hans Michael et al.Transplantation. 2002, Vol 74, Num 7, pp 982-986, issn 0041-1337Article

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis : Recommendations from an ad hoc international expert panelTEFFERI, Ayalew; THIELE, Juergen; REILLY, John T et al.Blood. 2007, Vol 110, Num 4, pp 1092-1097, issn 0006-4971, 6 p.Article

Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosisKRÖGER, Nicolaus; ZABELINA, Tatjana; THIELE, Jürgen et al.British journal of haematology. 2005, Vol 128, Num 5, pp 690-697, issn 0007-1048, 8 p.Article

Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapyKVASNICKA, Hans Michael; THIELE, Juergen; STAIB, Peter et al.Blood. 2004, Vol 103, Num 9, pp 3549-3551, issn 0006-4971, 3 p.Article

A prognostic model to predict survival in 867 World Health Organization―defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentPASSAMONTI, Francesco; THIELE, Jürgen; VANNUCCHI, Alessandro Maria et al.Blood. 2012, Vol 120, Num 6, pp 1197-1201, issn 0006-4971, 5 p.Article

Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cellsDEEPA PANTULU, N; PALLASCH, Christian P; KURZ, Anna Kordelia et al.Blood. 2010, Vol 116, Num 24, pp 5280-5284, issn 0006-4971, 5 p.Article

Impact of bone marrow morphology on multivariate risk classification in chronic myelogenous leukemiaKVASNICKA, Hans Michael; THIELE, Juergen; SCHMITT-GRAEFF, Annette et al.Acta haematologica. 2003, Vol 109, Num 1, pp 53-56, issn 0001-5792, 4 p.Article

  • Page / 2